Home Stock

Stock Research: Australian Clinical Labs

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Australian Clinical Labs

ASX:ACL AU0000148496
51
  • Value
    64
  • Growth
    59
  • Safety
    Safety
    16
  • Combined
    36
  • Sentiment
    69
  • 360° View
    360° View
    51
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

more

ANALYSIS: With an Obermatt 360° View of 51 (better than 51% compared with alternatives), overall professional sentiment and financial characteristics for the stock Australian Clinical Labs are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Australian Clinical Labs. The consolidated Value Rank has an attractive rank of 64, which means that the share price of Australian Clinical Labs is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 64% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 59, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 69. But the company’s financing is risky with a Safety rank of 16. This means 84% of comparable companies have a safer financing structure than Australian Clinical Labs. ...read more

more
Strongest Rank Leverage
Weakest Rank Pro Holdings
Country Australia
Industry Health Care Services
Size Medium
Website clinicallabs.com.au
Index
ASX 300
Australian Clinical Labs stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
64 n/a n/a n/a
Growth
59 n/a n/a n/a
Safety
Safety
16 n/a n/a n/a
Sentiment
69 n/a n/a n/a
360° View
360° View
51 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
20 n/a n/a n/a
Opinions Change
50 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
61 n/a n/a n/a
Sentiment
69 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
64 n/a n/a n/a
Growth
59 n/a n/a n/a
Safety Safety
16 n/a n/a n/a
Combined
36 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
83 n/a n/a n/a
Price vs. Earnings (P/E)
46 n/a n/a n/a
Price vs. Book (P/B)
19 n/a n/a n/a
Dividend Yield
89 n/a n/a n/a
Value
64 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
18 n/a n/a n/a
Profit Growth
28 n/a n/a n/a
Capital Growth
81 n/a n/a n/a
Stock Returns
86 n/a n/a n/a
Growth
59 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
3 n/a n/a n/a
Refinancing
25 n/a n/a n/a
Liquidity
32 n/a n/a n/a
Safety Safety
16 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Australian Clinical Labs and broaden your portfolio horizons.

Sinopharm

HKG:1099
Country: China
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Perseus

ASX:PRU
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Suzuken

TYO:9987
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews